Atlas Trials

MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma

Clinical trial NCT02575339 · TERMINATED

Trial details

NCT number
NCT02575339
Sponsor
Kathy Miller
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaLiver CancerHCC
Start date
2016-07-18
Primary completion
2018-06-26
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.